Regulatory15 May 2026, 06:51 pm
Fischer Medical Ventures: Monitoring Agency Report for Mar 2026
AI Summary
Fischer Medical Ventures Ltd. has released a Monitoring Agency Report by Infomerics Valuation and Rating Limited for the quarter ended March 31, 2026, concerning the utilization of funds raised through a preferential share issue. The report, as per SEBI regulations, indicates no deviation from the intended use of the ₹358.46 crore raised. The company has also placed the report on its website.
Key Highlights
- Infomerics Valuation and Rating Limited issued the Monitoring Agency Report.
- The report covers the quarter ended March 31, 2026.
- No deviation reported in the utilization of funds from the preferential issue.
- The preferential issue raised ₹358.46 crore.
- The report is available on Fischer Medical Ventures' website.
Price Impact
More from FISCHER
More in Regulatory